Ensysce Biosciences Reports Q3 2026 Financial Results

What Happened
Ensysce Biosciences, Inc. announced its quarterly financial results for the fiscal quarter ended June 30, 2026 by issuing a press release on August 13, 2026. The company filed a Form 8-K (Item 2.02) to disclose the results and attached the press release as an exhibit.

Key Details

• Filing date: August 13, 2026 (Form 8-K, Item 2.02).
• Reporting period: fiscal quarter ended June 30, 2026.
• The press release with the quarterly results is attached as Exhibit 99.1 to the 8-K.
• The filing also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters
Quarterly financial results provide updated information on Ensysce’s earnings, revenue trends, and financial condition—data that investors use to evaluate company performance and inform trading or investment decisions. The Form 8-K notifies the market that results are available; investors should review the attached press release and subsequent filings for the specific numbers and management commentary.